T. Lister

Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma.

T. Lister, A. Rohatiner, J. Lim, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma.

T. Lister, F. Morschhauser, P. Zinzani, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.